Idexx Laboratories Inc (I1DX34)
BOV
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current I1DX34 market cap is 45.29B. The company's latest EPS is USD 10.1749 and P/E is 39.99.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 943.63M | 915.53M | 901.6M | 964.1M | 1B |
| Operating Income | 296.14M | 275.28M | 246.4M | 298.96M | 263.8M |
| Net Income | 224.24M | 212.23M | 194.52M | 235.58M | 203.3M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2.41B | 2.71B | 3.22B | 3.37B | 3.66B |
| Operating Income | 552.85M | 694.52M | 932.03M | 898.77M | 1.1B |
| Net Income | 427.72M | 581.78M | 744.85M | 679.09M | 845.04M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.87B | 3.09B | 3.26B | 3.35B | 3.41B |
| Total Liabilities | 1.78B | 1.79B | 1.78B | 1.78B | 1.83B |
| Total Equity | 1.09B | 1.3B | 1.48B | 1.57B | 1.58B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.83B | 2.29B | 2.44B | 2.75B | 3.26B |
| Total Liabilities | 1.65B | 1.66B | 1.75B | 2.14B | 1.78B |
| Total Equity | 177.83M | 632.8M | 689.99M | 608.74M | 1.48B |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 384.23M | 656.66M | 906.51M | 198.59M | 446.9M |
| Investing | -66.98M | -94.82M | -125.25M | -106.94M | -139.85M |
| Financing | -297.11M | -340.15M | -442M | -144.07M | -354.31M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 459.16M | 648.06M | 755.55M | 542.98M | 906.51M |
| Investing | -205.53M | -109.38M | -292.97M | -195.35M | -125.25M |
| Financing | -286.41M | -248.42M | -697.41M | -370.94M | -442M |
| Market Cap | 45.29B |
| Price to Earnings Ratio | 39.99 |
| Price to Sales Ratio | 9.23 |
| Price to Cash Ratio | 74.45 |
| Price to Book Ratio | 22.77 |
| Dividend Yield | - |
| Shares Outstanding | 83.05M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 2 |
| 52 Week Change | 15.74% |
| 52 Week High | 575.20 |
| 52 Week Low | 454.80 |
| Spread (Intraday) | 184.36 (33.8%) |
| Company Name | Idexx Laboratories Inc |
| Address |
corporation trust center 1209 wilmington, delaware 19801 |
| Website | https://www.idexx.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
